NCT00784940View on ClinicalTrials.gov

ATAC - Bone Density Sub-Protocol

PHASE3CompletedINTERVENTIONAL

Enrollment

308

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

March 31, 2005

Study Completion Date

April 30, 2007

Conditions

Bone Density

Interventions

DRUG

Anastrozole

1mg, orally, once daily

DRUG

Tamoxifen

20mg, orally, once daily

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY